MétaCan
Menu
← Back to cohort
Record W7152933291

Transformative, Patient-Centric Care: Digital Screening Program Provides Equitable Access to Breast Cancer Risk Assessment and Genetic Testing.

2025· other· en· W7152933291 on OpenAlexaboutno aff
Jenna Cooke, Meghan Burgess, Heather Fecteau

Bibliographic record

VenuePubMed · 2025
Typeother
Languageen
Field
Topic
Canadian institutionsnot available
Fundersnot available
KeywordsBreast cancerRisk assessmentBreast cancer screeningGenetic testingCancer screeningRisk management toolsRisk stratificationCancer
DOInot available

Abstract

fetched live from OpenAlex

OBJECTIVE: Breast cancer screening disparities persist in the United States, underscoring the need for universal tools to provide equitable care. This study analyzes two years of data from 15 Midstate Radiology Associates (MRA) sites through Connecticut, where all women were offered a digital risk stratification platform. The platform is offered in five different languages and was designed to identify individuals at an elevated risk for breast cancer and determine eligibility for genetic testing based on national guidelines. MATERIALS AND METHODS: A retrospective analysis was conducted across MRA sites from 1/1/2023 to 12/31/2024 to evaluate patient demographics. Before mammograms, all patients were invited to the Ambry CARE Program to assess breast cancer risk using the Tyrer-Cuzick (v8.0) algorithm and determine eligibility for genetic testing based on NCCN® guidelines for hereditary cancers conditions. We analyzed patient ethnicity, age, and language preferences for those who completed the digital screening tool. High-risk patients, those eligible for genetic testing, and individuals who underwent testing-including those with positive mutations-were compared. RESULTS: Between 1/1/2023 and 12/31/2024, 91,513 assessments were sent to patients via SMS, email, and kiosks, with each method opened over 95% of the time. 77,095 assessments were completed, achieving an 84.2% completion rate. The tool supported over 1,100 patients in languages like Spanish, Polish, Chinese, and Vietnamese. Patient ethnicity was recorded as: White (73%), Hispanic/Latino (11%), Black/African American (6%), Asian (4%), French Canadian/Cajun (3%), Ashkenazi Jewish (2%), and 1% each for other ethnicities. 52% of respondents were aged 51-70, and 8,025 women (10.4%) had a Tyrer-Cuzick score over 20%. Among women with elevated lifetime breast cancer risk: White (71%), Hispanic/Latino (7.2%), Black/African American (5%), Asian (1.8%), French Canadian/Cajun (3.4%), Ashkenazi Jewish (2.6%), and 9% for other ethnicities. 67% were aged 41-60. Of 20,063 women (26%) eligible for genetic testing based on NCCN® guidelines, 69.4% were White, 8.6% Hispanic/Latino, 4.6% Black/African American, 1.7% Asian, 3.2% French Canadian/Cajun, 3.6% Ashkenazi Jewish, and 8.9% other ethnicities. 52% were aged 51-70. 6,051 women chose genetic testing, with 451 (9%) receiving positive results. Age and ethnicity distributions were similar across these groups with increase in percentage of Latin/Hispanic opting for genetic testing. CONCLUSION: The digital tool effectively stratified breast cancer risk across diverse patient population, promoting equitable screening and education through multilingual options and personalized support.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.003
metaresearch head score (Gemma)0.009
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Other · Consensus signal: none
Teacher disagreement score0.011
Threshold uncertainty score0.021

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0030.009
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.001
Science and technology studies0.0010.001
Scholarly communication0.0020.001
Open science0.0010.004
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0060.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.026
GPT teacher head0.292
Teacher spread0.266 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreOther

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venuePubMed→French-language works237,207→